Bibliographic update: Immunocryosurgery, a therapeutic alternative for invasive basal cell carcinomas

Authors

  • María Belén Mariucci Vázquez Dermatology Unit, Dr. Cosme Argerich General Acute Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v26i3.2106

Keywords:

immunocryosurgery, therapeutic alternative, invasive basal cell carcinomas

Abstract

Basal cell carcinoma is the most prevalent malignant neoplasm and a very frequent pathology of dermatological consultation.

Conventional surgery and Mohs micrographic surgery represent the first treatment option, but there are numerous second-line alternatives such as topical treatment with 5-fluorouracil or imiquimod, cryosurgery and photodynamic therapy, with lower response rates and higher recurrence rates.

References

I. Gaitanis G, Bassukas ID. Immunocryosurgery for non-superficial basal cell carcinoma: a prospective, open-label phase III study for tumours < 2 cm in diameter. Acta Derm Venereol 2014;94:38-44.

II. Gaitanis G, Bassukas ID. Immunocryosurgery for non-superficial basal cell carcinomas ≤ 20 mm in maximal diameter: Five-year follow-up. J Geriatr Oncol 2019;10:475-478.

Downloads

Published

2020-09-15

Issue

Vol. 26 No. 3 (2020): July-September 2020

Section

Young Dermatologists

License

El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.

 

Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor